isocitric acid has been researched along with Glial Cell Tumors in 3 studies
isocitric acid: RN given refers to unlabeled parent cpd
isocitric acid : A tricarboxylic acid that is propan-1-ol with a hydrogen at each of the 3 carbon positions replaced by a carboxy group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Y | 1 |
| Lv, W | 1 |
| Li, Q | 1 |
| Wang, Q | 1 |
| Ru, Y | 1 |
| Xiong, X | 1 |
| Yan, F | 1 |
| Pan, T | 1 |
| Lin, W | 1 |
| Li, X | 1 |
| Kato, Y | 1 |
| Smeitink, J | 1 |
1 review available for isocitric acid and Glial Cell Tumors
| Article | Year |
|---|---|
Specific monoclonal antibodies against IDH1/2 mutations as diagnostic tools for gliomas.
Topics: Antibodies, Monoclonal; Arginine; Biomarkers, Tumor; Brain Neoplasms; Catalysis; Cytosol; Glioma; Gl | 2015 |
2 other studies available for isocitric acid and Glial Cell Tumors
| Article | Year |
|---|---|
IDH2 compensates for IDH1 mutation to maintain cell survival under hypoxic conditions in IDH1‑mutant tumor cells.
Topics: Carcinogenesis; Cell Survival; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Glioma; HC | 2019 |
Metabolism, gliomas, and IDH1.
Topics: Brain Neoplasms; Genetic Markers; Glioma; Glutarates; Humans; Isocitrate Dehydrogenase; Isocitrates; | 2010 |